Treating Periodontal Disease In The Post-Antibiotic Age

June 14, 2024

9am to 1pm

  • Price: $250 (in person) ⎸ $99 (virtual)
  • Audience: DR/RDH
  • Location: Hybrid
  • AGD Code: 490
  • Credits: 4 CE
  • course description

    Treating periodontal disease not only improves oral health, it also reduces a chronic infectious burden on patients’ immune systems. Unfortunately, it is one of the most underdiagnosed diseases. Forty-seven percent of American adults have chronic periodontitis. However, according to Dental Intel, only 8% of patients get treatment planned for D4341 and D4342. Of that 8%, only half accept the treatment. Without a diagnosis, patients cannot make informed decisions or get the care they need.

    Antibiotic adjunctive therapies have a temporary, limited effect. This is because biofilms repopulate after usage and because we are in the post-antibiotic age. A broad-spectrum antimicrobial like hydrogen peroxide is an excellent alternative for patients with gingivitis, periodontitis, peri-implant mucositis, and peri-implantitis. Attend this presentation to learn the science behind the use of peroxide for the treatment of biofilm-based diseases.

    course objectives

    • Identify the benefits and limitations of antimicrobials with oxidative and oxygenating reactions for biofilm management.
    • Recognize patient candidates who can benefit from Rx Tray therapy of peroxide.
    • Evaluate clinical cases and the efficacy of peroxide in treatment.

    course schedule

    • breakfast & registration: 8am
    • lecture: 9am to 1pm

    Midwest Center For Dental Education